MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.380
+0.110 (8.66%)
At close: Aug 13, 2025, 4:00 PM
1.500
+0.120 (8.70%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
MaxCyte Stock Forecast
MXCT's stock price has decreased by -65.76% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for MaxCyte stock ranges from a low of $6.00 to a high of $9.00. The average analyst price target of $7.50 forecasts a 443.48% increase in the stock price over the next year.
Price Target: $7.50 (+443.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MaxCyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +334.78% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +552.17% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +697.10% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
41.86M
from 38.63M
Increased by 8.36%
Revenue Next Year
50.29M
from 41.86M
Increased by 20.14%
EPS This Year
-0.39
from -0.39
EPS Next Year
-0.38
from -0.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.0M | 54.4M | 93.3M | ||
| Avg | 41.9M | 50.3M | 90.6M | ||
| Low | 39.4M | 45.1M | 87.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.9% | 29.9% | 85.5% | ||
| Avg | 8.4% | 20.1% | 80.2% | ||
| Low | 1.9% | 7.7% | 73.2% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.36 | -0.35 |
| Avg | -0.39 | -0.38 |
| Low | -0.41 | -0.39 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.